The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegalyGILBERT, J. A; MIELL, J. P; CHAMBERS, S. M et al.Clinical endocrinology (Oxford. Print). 2005, Vol 62, Num 6, pp 742-747, issn 0300-0664, 6 p.Article

FSH secretion predominates in vivo and in vitro in patients with non-functioning pituitary adenomasHANSON, P. L; AYLWIN, S. J. B; MONSON, J. P et al.European journal of endocrinology. 2005, Vol 152, Num 3, pp 363-370, issn 0804-4643, 8 p.Article

Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesityYANG, L; SAMARASINGHE, Y. P; KANE, P et al.Clinical endocrinology (Oxford. Print)). 2010, Vol 73, Num 2, pp 197-200, issn 0300-0664, 4 p.Article

Attenuated peptide YY release in obese subjects is associated with reduced satietyLE ROUX, C. W; BATTERHAM, R. L; BLOOM, S. R et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 1, pp 3-8, issn 0013-7227, 6 p.Article

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumorsKORBONITS, M; JACOBS, R. A; BESSER, G. M et al.The Journal of clinical endocrinology and metabolism. 1998, Vol 83, Num 10, pp 3624-3630, issn 0021-972XArticle

Effects of pituitary adenylate cyclase-activating polypeptide on hormone secretion by human pituitary adenomas in vitroDESAI, B. J; MONSON, J. P; HOLDSTOCK, J. G et al.The Journal of clinical endocrinology and metabolism. 1994, Vol 79, Num 6, pp 1771-1777, issn 0021-972XArticle

Temozolomide in the management of dopamine agonist― resistant prolactinomasWHITELAW, B. C; DWORAKOWSKA, D; GILBERT, J. A et al.Clinical endocrinology (Oxford. Print). 2012, Vol 76, Num 6, pp 877-886, issn 0300-0664, 10 p.Article

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satietyBORG, C. M; LE ROUX, C. W; GHATEI, M. A et al.British journal of surgery. 2006, Vol 93, Num 2, pp 210-215, issn 0007-1323, 6 p.Conference Paper

The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas : Hormones and reproductive healthAYLWIN, S. J. B; WELCH, J. P; DAVEY, C. L et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 6, pp 2476-2483, issn 0021-972XArticle

Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumors : an in vitro and immunohistochemical studyDESAI, B; BURRIN, J. M; NOTT, C. A et al.European journal of endocrinology. 1995, Vol 133, Num 1, pp 25-32, issn 0804-4643Article

Phaeochromcytoma crisisWHITELAW, B. C; PRAGUE, J. K; MUSTAFA, O. G et al.Clinical endocrinology (Oxford. Print). 2014, Vol 80, Num 1, pp 13-22, issn 0300-0664, 10 p.Article

The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomasHUNTER, J. A. C; SKELLY, R. H; AYLWIN, S. J. B et al.European journal of endocrinology. 2003, Vol 148, Num 2, pp 203-211, issn 0804-4643, 9 p.Article

Expression and secretion of neural cell adhesion molecules by human pituitary adenomasDE JONG, I; AYLWIN, S. J. B; OLABIRAN, Y et al.Annals of clinical biochemistry. 1999, Vol 36, pp 660-665, issn 0004-5632, 5Article

Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomasAYLWIN, S. J. B; KING, A; BLENKE, A et al.European journal of endocrinology. 1998, Vol 139, Num 4, pp 378-386, issn 0804-4643Article